Activation of extracellular signal-regulated protein kinase 5 downregulates FasL upon osmotic stress

Cell Death and Differentiation

Volumn 13, Issue 12, 2006, Pages 2099-2108

  Wang, X ^a   Finegan, K G ^a   Robinson, A C ^a   Knowles, L ^a   Khosravi Far, R ^b   Hinchliffe, K A ^a   Boot Handford, R P ^c   Tournier, C ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; MITOGEN ACTIVATED PROTEIN KINASE 7; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SORBITOL; TRANSCRIPTION FACTOR FKHRL1;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; FIBROBLAST; MOUSE; NONHUMAN; OSMOTIC STRESS; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; APOPTOSIS; CELLS, CULTURED; DOWN-REGULATION; FAS LIGAND PROTEIN; FIBROBLASTS; FORKHEAD TRANSCRIPTION FACTORS; GENE DELETION; MAP KINASE KINASE 5; MICE; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASE 7; OSMOTIC PRESSURE; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; SORBITOL;

EID: 33750997878     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401969     Document Type: Article

References (39)

1. Johnson GL and Lapadat R (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912.
2. Lee JD, Ulevitch RJ and Han J (1995) Primary structure of BMK1: A new mammalian map kinase. Biochem. Biophys. Res. Commun. 213: 715-724.
3. Zhou G, Bao ZQ and Dixon JE (1995) Components of a new human protein kinase signal transduction pathway. J. Biol. Chem. 270: 12665-12669.
4. Wang X, Merritt AJ, Seyfried J, Guo C, Papadakis ES, Finegan KG, Kayahara M, Dixon J, Boot-Handford RP, Cartwright EJ, Mayer U and Tournier C (2005) Targeted deletion of mek5 causes early embryonic death and defects in the ERK5/MEF2 cell survival pathway. Mol. Cell. Biol. 25: 336-345.
5. Kato Y, Kravchenko V, Tapping RI, Han J, Ulevitch RJ and Lee J-D (1997) BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J. 16: 7054-7066.
6. Kato Y, Zhao M, Morikawa A, Sugiyama T, Chakravortty D, Koide N, Yoshida T, Tapping RI, Yang Y, Yokochi T and Lee J-D (2000) Big mitogen-activated kinase regulates multiple members of the MEF2 protein family. J. Biol. Chem. 275: 18534-18540.
7. Kayahara M, Wang X and Tournier C (2005) Selective regulation of c-jun gene expression by the mitogen-activated protein kinases via the TPA-responsive element and the myocyte enhancer factor 2 binding sites. Mol. Cell. Biol. 25: 3784-3792.
8. Hayashi M and Lee J-D (2004) Role of the BMK1/ERK5 signaling pathway: lessons from knockout mice. J. Mol. Med. 82: 800-808.
9. Hayashi M, Kim SW, Imanaka-Yoshida K, Yoshida T, Abel ED, Eliceiri B, Yang Y, Ulevitch RJ and Lee J-D (2004) Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure. J. Clin. Invest. 113: 1138-1148.
10. Pi X, Yan C and Berk BC (2004) Big mitogen-activated protein kinase (BMK1)/ERK5 protects endothelial cells from apoptosis. Cir. Res. 94: 362-369.
11. Cavanaugh JE (2004) Role of extracellular signal regulated kinase 5 in neuronal survival. Eur. J. Biochem. 271: 2056-2059.
12. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P and Hemmings BA (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15: 6541-6551.
13. Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB and Cohen P (1997) Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr. Biol. 7: 261-269.
14. Sarbassov DD, Guertin DA, Ali SM and Sabatini DM (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-1101.
15. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y and Greenberg ME (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91: 231-241.
16. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J and Greenberg ME (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868.
17. Puthalakath H, Huang DC, O'Reilly LA, King SM and Strasser A (1999) The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol. Cell 3: 287-296.
18. Faris M, Latinis KM, Kempiak SJ, Koretzky GA and Nel A (1998) Stress-induced Fas ligand expression in T cells is mediated through a MEK kinase 1-regulated response element in the Fas ligand promoter. Mol. Cell. Biol. 18: 5414-5424.
19. Kolbus A, Herr I, Schreiber M, Debatin KM, Wagner EF and Angel P (2000) c-Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents. Mol. Cell. Biol. 20: 575-582.
20. Sohn SJ, Sarvis BK, Cado D and Winoto A (2002) ERK5 MAPK regulates embryonic angiogenesis and acts as a hypoxia-sensitive repressor of vascular endothelial growth factor expression. J. Biol. Chem. 277: 43344-43351.
21. Buschbeck M and Ulrich A (2005) The unique C-terminal tail of the mitogen-activated protein kinase ERK5 regulates its activation and nuclear shuttling. J. Biol. Chem. 280: 2659-2667.
22. Suhara T, Kim HS, Kirshenbaum LA and Walsh K (2002) Suppression of Akt signaling induces Fas ligand expression: Involvement of caspase and Jun kinase activation in Akt-mediated Fas ligand regulation. Mol. Cell. Biol. 22: 680-691.
23. Dijkers PF, Medema RH, Lammers JW, Koenderman L and Coffer PJ (2000) Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr. Biol. 10: 1201-1204.
24. Tang D, Okada H, Ruland J, Liu L, Stambolic V, Mak TW and Ingram AJ (2001) Akt is activated in response to an apoptotic signal. J. Biol. Chem. 276: 30461-30466.
25. Konishi H, Matsuzaki H, Tanaka M, Ono Y, Tokunaga C, Kuroda S and Kikkawa U (1996) Activation of RAC-protein kinase by heat shock and hyperosmolarity stress through a pathway independent of phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. USA 93: 7639-7643.
26. Meier R, Thelen M and Hemmings BA (1998) Inactivation and dephosphorylation of protein kinase Balpha (PKBalpha) promoted by hyperosmotic stress. EMBO J. 17: 7294-7303.
27. 2 or heat shock is mediated by phosphoinositide 3-kinase and not by mitogen-activated protein kinase-activated protein kinase-2. Biochem. J. 336: 241-246.
28. Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA and Davis RJ (2000) Requirement of JNK for stress-induced activation of the cytochrome c- mediated death pathway. Science 288: 870-874.
29. Sunayama J, Tsuruta F, Masuyama N and Gotoh Y (2005) JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3. J. Cell Biol. 170: 295-304.
30. Faris M, Kokot N, Latinis K, Kasibhatla S, Green DR, Koretzky GA and Nel A (1998) The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression. J. Immunol. 160: 134-144.
31. Le-Niculescu H, Bonfoco E, Kasuya Y, Claret F-X, Green DR and Karin M (1999) Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death. Mol. Cell. Biol. 19: 751-763.
32. Xia Z, Dickens M, Raingeaud J, Davis RJ and Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331.
33. Yeh J-H, Hsu S-C, Han S-H and Lai M-Z (1998) Mitogen-activated protein kinase kinase antagonized fas-associated death domain protein-mediated apoptosis by induced FLICE-inhibitory protein expression. J. Exp. Med. 188: 1795-1802.
34. Watson FL, Heerssen HM, Bhattacharyya A, Klesse L, Lin MZ and Segal RA (2001) Neurotrophins use the Erk5 pathway to mediate a retrograde survival response. Nat. Neurosci. 4: 981-988.
35. Hawkes NA and Roberts SGE (1999) The Role of human TFIIB in transcription start site selection in vitro and in vivo. J. Biol. Chem. 274: 14337-14343.
36. Serunian LA, Auger KR and Cantley LC (1991) Identification and quantification of polyphosphoinositides produced in response to platelet derived growth factor stimulation. Methods Enzymol. 198: 78-87.
37. Seyfried J, Wang X, Kharebava G and Tournier C (2005) A novel MAPK docking site in the N-terminus of MEK5α organizes the components of the ERK5 signaling pathway. Mol. Cell. Biol. 25: 9820-9828.
38. Jonsson H, Allen P and Peng SL (2005) Inflammatory arthritis requires Foxo3a to prevent Fas ligand-induced neutrophil apoptosis. Nat. Med. 11: 666-671.
39. Livak KL and Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Methods 25: 402-408.